Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 209 participants.
Also called NCT02081118
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 209 participants
- Registry
-
NCT02081118
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02081118. Randomized; triple masking; primary purpose treatment. Start 2014-02 (registry gives no type); primary completion 2015-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- HM11260C
- Intervention (Drug)
- Placebo
- Lead sponsor
- Hanmi Pharmaceutical Company Limited
Record details
- Record id
cardio:ct-nct02081118- Content hash
ccc2ffc51f62d1d4d52f502228053c780816ba4c76bcc4d853ae503df2adf4c8